Grand Pharmaceutical Group Limited (HKG:0512)

Hong Kong · Delayed Price · Currency is HKD

7.56

+0.01 (0.13%)

Feb 13, 2026, 4:08 PM HKT

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Pharmaceutical Technology Products	7.32B
Pharmaceutical Technology Products Growth	7.41%
Bio-technology Products	3.51B
Bio-technology Products Growth	3.84%
Nuclear Medicine Anti-tumor Diagnosis and Treatment and Cerebro-cardiovascular Precision Interventional Diagnosis and Treatment Technology Products	816.21M
Nuclear Medicine Anti-tumor Diagnosis and Treatment and Cerebro-cardiovascular Precision Interventional Diagnosis and Treatment Technology Products Growth	143.36%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
China	10.05B
China Growth	15.18%
America	589.43M
America Growth	-14.26%
Europe	478.29M
Europe Growth	-14.93%
Asia	474.96M
Asia Growth	-7.25%
Other	55.98M
Other Growth	22.03%